Ferring’s European Marketing Authorisation Application for controlled release misoprostol vaginal delivery system for the induction of labour accepted for review
- by pulseFerring Pharmaceuticals announced today that it has received confirmation from European health authorities that the Marketing Authorisation…
pulseFerring Announces FDA Acceptance of NDA Filing for Controlled Release Misoprostol Vaginal Insert for Decreasing Time to Vaginal Delivery in Women
- by pulseFerring Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA)…
pulseNew study showed desmopressin melt reduced sleep disruption in bedwetting children
- by pulsePreliminary results from a new, prospective study presented today at the first Joint Congress of the International Children’s Continence…
pulseFonds de solidarité FTQ, CTI Life Sciences Fund and Ferring Pharmaceuticals Create a New Biotech in Québec
- by pulseThe Fonds de solidarité FTQ (the “Fonds”), CTI Life Sciences Fund and Ferring Pharmaceuticals are pleased to announce…
pulseFDA approves Ferring’s PREPOPIK™ (sodium picosulfate, magnesium oxide, and anhydrous citric acid) for colonoscopy prep
- by pulseThe U.S. Food and Drug Administration (FDA) granted Ferring Pharmaceuticals Inc. approval to market PREPOPIK (sodium picosulfate, magnesium…
pulse
- 1
- 2